Microbiota Therapy
Fecal Microbiota Transplant for Hidradenitis Suppurativa
Recruiting0 awardsPhase < 1
Minneapolis, Minnesota
This trial looks into a new treatment for HS with only one FDA-approved option. It hopes to investigate if gut microbiome changes can improve HS, which significantly reduces quality of life & has high medical costs.
Popular Filters
Trials for HS Patients
Temporizing Matrix
BTM vs Human Cadaveric Allograft for Hidradenitis Suppurativa
Recruiting3 awardsPhase 4
Augusta, Georgia
This trial compares a new wound treatment with standard methods in patients with Hidradenitis suppurativa. The new treatment helps wounds heal by providing a temporary structure for new tissue growth, while standard methods use traditional wound care techniques. The new treatment has shown positive outcomes in healing burns and plastic surgery wounds, but its effectiveness in diabetic foot wounds has not yet been established.
Monoclonal Antibodies
Lutikizumab for Hidradenitis Suppurativa
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial is testing a new drug called lutikizumab to help adults with a painful skin condition called hidradenitis suppurativa (HS) who haven't been helped by other treatments. The drug works by reducing inflammation in the skin.
Monoclonal Antibodies
Bimekizumab for Hidradenitis Suppurativa
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is testing the safety of bimekizumab, a medication for people with moderate to severe hidradenitis suppurativa (HS). Bimekizumab aims to reduce inflammation and alleviate symptoms by targeting certain proteins in the body.
Phase 3 Trials
Monoclonal Antibodies
Bimekizumab for Hidradenitis Suppurativa
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is testing the safety of bimekizumab, a medication for people with moderate to severe hidradenitis suppurativa (HS). Bimekizumab aims to reduce inflammation and alleviate symptoms by targeting certain proteins in the body.
Janus Kinase (JAK) Inhibitor
Upadacitinib for Hidradenitis Suppurativa
Recruiting1 awardPhase 3
Phoenix, Arizona
This trial is testing if a daily pill called upadacitinib can help people with a painful skin condition called hidradenitis suppurativa (HS) who haven't responded to usual treatments. The study will involve adults and teenagers and will check for safety and effectiveness over time. Participants will be randomly given either the medication or a non-active pill, and their progress will be monitored through periodic medical check-ups.
Monoclonal Antibodies
Spesolimab for Hidradenitis Suppurativa
Recruiting0 awardsPhase 2 & 3
Barrie, Ontario
This trial tests spesolimab, a drug that may help adults with moderate to severe hidradenitis suppurativa (HS). It works by calming the immune system to reduce inflammation and heal the skin. The study aims to see if spesolimab is effective and safe for these patients.
Trials With No Placebo
Temporizing Matrix
BTM vs Human Cadaveric Allograft for Hidradenitis Suppurativa
Recruiting3 awardsPhase 4
Augusta, Georgia
This trial compares a new wound treatment with standard methods in patients with Hidradenitis suppurativa. The new treatment helps wounds heal by providing a temporary structure for new tissue growth, while standard methods use traditional wound care techniques. The new treatment has shown positive outcomes in healing burns and plastic surgery wounds, but its effectiveness in diabetic foot wounds has not yet been established.
Monoclonal Antibodies
Bimekizumab for Hidradenitis Suppurativa
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is testing the safety of bimekizumab, a medication for people with moderate to severe hidradenitis suppurativa (HS). Bimekizumab aims to reduce inflammation and alleviate symptoms by targeting certain proteins in the body.
Janus Kinase (JAK) Inhibitor
Topical Ruxolitinib Cream for Hidradenitis Suppurativa
Recruiting1 awardPhase 2
Hershey, Pennsylvania
This trial is testing whether a cream containing the drug ruxolitinib can reduce disease activity in people with HS. Investigators will also study how this drug affects inflammation by looking at skin biopsy samples.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.